Sarepta Therapeutics (SRPT) Free Cash Flow Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.32% |
| Dec 31, 2025 | 21.32% |
| Sep 30, 2025 | 32.28% |
| Jun 30, 2025 | 30.68% |
| Mar 31, 2025 | -24.69% |
| Dec 31, 2024 | 18.11% |
| Sep 30, 2024 | -7.03% |
| Jun 30, 2024 | 31.70% |
| Mar 31, 2024 | -11.06% |
| Dec 31, 2023 | 12.37% |
| Sep 30, 2023 | -1.59% |
| Jun 30, 2023 | -2.16% |
| Mar 31, 2023 | -35.55% |
| Dec 31, 2022 | -23.48% |
| Sep 30, 2022 | -4.52% |
| Jun 30, 2022 | 2.92% |
| Mar 31, 2022 | -11.35% |
| Dec 31, 2021 | 17.82% |
| Sep 30, 2021 | -16.80% |
| Jun 30, 2021 | -21.36% |
| Mar 31, 2021 | -26.64% |
| Dec 31, 2020 | -44.40% |
| Sep 30, 2020 | -40.89% |
| Jun 30, 2020 | -34.16% |
| Mar 31, 2020 | 74.33% |
| Dec 31, 2019 | -44.65% |
| Sep 30, 2019 | -9.97% |
| Jun 30, 2019 | -16.80% |
| Mar 31, 2019 | -37.06% |
| Dec 31, 2018 | -50.57% |
| Sep 30, 2018 | -44.46% |
| Jun 30, 2018 | -58.91% |
| Mar 31, 2018 | -26.10% |
| Dec 31, 2017 | -37.32% |
| Sep 30, 2017 | -49.83% |
| Jun 30, 2017 | -72.18% |
| Mar 31, 2017 | -47.08% |
| Dec 31, 2016 | -70.42% |
| Sep 30, 2016 | -51.03% |
| Jun 30, 2016 | -117.83% |
| Mar 31, 2016 | -43.14% |
| Dec 31, 2015 | -72.93% |
| Sep 30, 2015 | -73.02% |